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Over the past several years, the anticancer drugs 
exhibited their effects on tumor cells by combating 
cancer cells proliferation. Since the last decade, 
however, it has been evident that anticancer drugs are 
capable of inducing apoptosis in proliferating tumor 
cells and this mechanism is attributable to the exertion 
of their cytotoxic effects. Consequently, anticancer 
therapies focus on accelerating apoptosis in cancer 
cells and possess significant therapeutic activity 
1, 2
. 
Based on this strategy, a plethora of research work is 
going on globally for synthesizing novel effective 
apoptogenic compounds or isolating these therapeutic 
agents from natural sources 
3
. However, one of the 
major drawbacks of these chemical and synthetic 
anticancer drugs involves numerous toxic side effects 
and in the present scenario, researchers are focusing on 
the discovery of potential novel anticancer agents from 
natural sources such as animal venoms and toxins 
without possessing any potential necrotic effects 
4, 5
. 
Snake venom comprises of biologically active 
polypeptides and non-polypeptide constituents
 6, 7
. 
Among the various venomic constituents snake venom 
cytotoxins and short neurotoxins are generally 
nonenzymatic polypeptide moieties having a molecular 
weight of 5-10 kDA 
6
. Fifty percent of the dry weight 




So far, numerous cytotoxins were isolated from 
different species of snake venom and investigated for 
their potential cytotoxic activity and other related 
mechanisms. From the earlier investigations, it was 
evident that basic residues in cytotoxins structure 
(namely Lys and Arg) interact with phospholipids of 
cell membrane and form pores on cell membranes that 
may result into severe membrane damage and necrotic 
cell death 
9, 10, 11, 12
. 
WŰster investigated that the spitting cobras of 
Southeast Asia, formerly known collectively as Naja 
sputatrix (earlier known as Malayan cobra) generally 
comprises of three distinct species: Naja sumatrana 
(Equatorial spitting cobra) in Peninsular Malaysia and 
Sumatra, Naja siamensis (Indochinese spitting cobra) 
in Thailand, and Naja sputatrix (Javan spitting cobra) 




Snake venom cytotoxin from different Naja species possesses significant cytotoxic activity on tumor cells. The cytoxin 
from snake venom can exert a plethora of biological activities including depolarization and muscular cell contraction, lysis 
of variety of cells such as red blood cells, epithelial cells and fetal lung cells, and also apoptotic activity on certain types of 
tumor cells. In the present article, we have effectively utilized comparative modeling approach to propose the first molecular 
model structure of cytotoxin 1 of Naja sputatrix.  The charge distribution on the structure and distribution of secondary 
structural elements were also investigated with the aid of In silico based approach. A homology structural model of the 
protein was generated and analyzed to deduce molecular enrichment strategy. The model data and other relevant post model 
analysis data provides a clear understanding of molecular structure of cytotoxin 1 of Naja sputatrix and its relevant 
cytotoxic potential for the development of a beneficial anticancer natural lead compound.   
Keywords: Cytotoxin 1, Naja Sputatrix, Anticancer Agent, Snake Venom, Structural model, Malayan cobra. 
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Earlier research experimnets on six Naja sputatrix (N. 
sputatrix) cytotoxin isoforms manifested that they 
revealed varying degrees of cytolytic potency 
14
. By 
comparing the primary sequences of these cytotoxins, 
it was analyzed that the majority of the conserved 
amino acid residues plays a vital role in structural 
organization, forming the three- finger loop 
conformations, thereby conserving the structural 
scaffold, whereas the variable residues around the tips 
of the loops are involved in exhibiting their significant 
biological activities 
15
. Loop II is known to be the most 
crucial cytolytic domain for these cytotoxins 
14
. 
With this present scenario the objective of this study 
was to determine a homology based structure of 
Cytotoxin 1 of N. sputatrix. The other contributory 
objective was to investigate the charge distribution on 
the structure and distribution of secondary structural 
elements with the aid of In silico based approach. The 
generated and validated structure may be utilized in 
the future as a template for the development of vaccine 
and other beneficial therapeutic development. 
MATERIALS AND METHODS 
The starting material i.e., amino acid sequence of 
cytotoxin 1 of N. sputatrix was collected from National 
Centre for Biotechnology Information 
(http://ncbi.nlm.nih.gov) 
16
. Comparative molecular 
model of cytotoxin 1 of N. sputatrix was created with 
the help of iterative implementation of the threading 
assembly refinement algorithm 
17
. Energy 
minimization procedure for structural betterments of 
molecular model of cytotoxin 1 of N. sputatrix was 
performed by Swiss-PDB Viewer 
18
. Validation of 
structural model obtained by comparative modeling 
strategy was analyzed by PROCHECK algorithm, 
ProSA and QMEANclust tool 
19, 20, 21
. Position of 
secondary structural components and distribution of 
positive and negative charge over the structure was 




RESULTS AND DISCUSSION 
The three-dimensional structures of the three-fingered 
toxins (cytotoxins) signify that the backbone of 
members of this family comprises of a globular core 
possessing four disulphide bridges and three-fingers 
emerging from the core. By comparing the structural 
and evolutionary behavior, it was demonstrated that 
the globular core retains the overall structure of these 
toxins, while major structural plasticity appears at the 
tips of the loops 
24, 25, 26, 27
. Recently, several researches 
have suggested that the slight alterations in these loop 
regions might lead to the functional differences among 
the toxins 
28
. By investigating several biological 
activities of cytotoxins, their cytolytic and/or 
haemolytic functions are the most widely explored. 
The lytic activity of cytotoxins is attributable to their 




Snake venom cytotoxins are extremely hydrophobic 
and basic polypeptides. It is interesting to note that 
cytotoxins can exhibit a wide range of biological 
activities, such as depolarization and muscular cell 
contraction, lysis of several types of cells including red 
blood cells, epithelial cells and fetal lung cells, and 




PROCHECK analysis or Ramachandran plot 
evaluation is a good standard for validation purpose of 
protein structure models. Ramachandran plot for 
cytotoxin 1 of N. sputatrix has been illustrated in 
Figure 1. In summary 100% of the residues of the 
cytotoxin 1 structure were observed in allowed and 
favored regions, which successively substantiate the 
predication of generated protein structural model. 
PROCHECK tool also displayed 74.5% of residues in 
the most favored regions, with 23.5% residues in 
additionally allowed regions, respectively (Figure 1). 
This validated that the protein structural backbone 
dihedral angles, phi and psi, in the cytotoxin 1 of N. 
sputatrix, were reasonably accurate. This asserts that 
the three dimensional modeled structure of cytotoxin 1 
of N. sputatrix is commensurate and satisfactory 
(Figure 2).  
As shown in Figure 3 the Z-score (ProSA tool) of 
cytotoxin 1 of N. sputatrix was – 4.39. The result was 
properly inside the range of scores normally regarded 
for proteins of equal size, demonstrating highly 
reliable structures. The QMEANclust algorithm also 
hints an appropriate quality of the structural co-
ordinates of cytotoxin 1 of N. sputatrix with a 
QMEANscore of 0.628 and Z-Score of -0.533. 
The visual inspection of cytotoxin 1 of N. sputatrix 
postulates that the total protein is composed by 60 
numbers of amino acids. The presence of total number 
of positively charged amino acids is 11 (Figure 4). In 
contrast to that the total number of negatively charged 
amino acids is only 2 (Figure 5). The molecular weight 
and theoretical pI of cytotoxin 1 of N. sputatrix is 
6729.2 and 9.38 respectively. 
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Figure 1: Ramachandran plot analysis of molecular model of Cytotoxin 1 of Naja sputatrix. 
 
 
Figure 2: Three-dimensional modeled structure of 
Cytotoxin 1 
 
Figure 3: Stereo-chemical analysis of modeled 
structure of Cytotoxin 1 of Naja sputatrix.  
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Figure 4: Positively charged amino acid 
distribution on the modeled structure of Cytotoxin 
1 of Naja sputatrix. 
 
Figure 5: Negatively charged amino acid 
distribution on the modeled structure of Cytotoxin 
1 of Naja sputatrix. 
 
CONCLUSION 
In the present study, we have effectively employed 
comparative modeling approach to propose the first 
molecular model structure of cytotoxin 1 of Naja 
sputatrix. The cytotoxin 1 of Naja sputatrix plays a 
significant role in Naja sputatrix venom to assault 
different preys and in has prospective to turn into a 
benefical anti-cancer natural compound. Therefore, it 
would be an interesting approach to deduce its 
molecular function and propose mechanism of action. 
Consequently, a homology structural model of the 
protein was developed and further analysis was 
carried out to infer molecular enrichment strategy. 
The model data in addition to other relevant post 
model analysis data put forward molecular insight to 
cytotoxic property of cytotoxin 1 of Naja sputatrix 
function towards the clear understanding of anti-
cancer natural lead molecule. 
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